Vitro Diagnostics Inc. (fka VODG)

[Potse]

Ivan Rich...June 15 conference presentation.....

Hemogenix CEO Ivan Rich (VODG's strategic partner) will be the Chairman of the "Stem Cell and Bone Marrow Toxicity" session at the 10th International Conference on Early Toxicity Screening (June 14-15, Seattle).

Rich will also be making a presentation during this session.....

8:30 AM – 9:00 AM
Stem Cell In Vitro Screening Models for Toxicity Testing
(Ivan Rich, Hemogenix; Colorado Springs, CO) Predicting
toxicity is a task stem cells can perform very well. They provide
a wealth of predictive information for the cell system they
supply and maintain. This has been proven many times using
primary stem cells, for example, stem cells of the bloodforming
system. More recently, ES and iPS cells as well as
cells derived from these sources have started to be used to
predict toxicity. This could be an important avenue for many
aspects of drug development and other applications. The
question is whether these new stem cells products exhibit the
same response as their primary stem cell counterparts.

Page 3......

http://www.ifscomm.org/ETS-2012.pdf